LONDON (ShareCast) - (Sharecast News) - Iconic UK shoemaker Dr Martens held annual guidance and said it continued to see positive trading in its Americas direct to consumer operations, driven by full price sales, although its UK business continued to experience a challenging trading backdrop.
In a trading update on Thursday, the company said autumn/winter order books globally were healthy, with EMEA up year-on-year, while the Americas was broadly in line year-on-year and based on a much wider product range than previously. Dr Martens added that its earnings performance would be second-half weighted.

Its Asia-Pacific business "continues to show good growth, with a particularly strong performance in South Korea driven by our well-established shoes category here".

Reporting by Frank Prenesti for Sharecast.com

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE